NDC 69761-222

Testosterone / Anastrozole

Testosterone / Anastrozole

Testosterone / Anastrozole is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Qualgen Llc. The primary component is Anastrozole; Testosterone.

• Product ID: 69761-222_41911ad7-2937-46ba-8375-6de66c99975c
• NDC: 69761-222
• Product Type: Human Prescription Drug
• Proprietary Name: Testosterone / Anastrozole
• Generic Name: Testosterone / Anastrozole
• Dosage Form: Pellet
• Route of Administration: ORAL
• Marketing Start Date: 2017-11-14
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Qualgen LLC
• Substance Name: ANASTROZOLE; TESTOSTERONE
• Active Ingredient Strength: 20 mg/1; mg/1
• Pharm Classes: Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA],Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [CS]
• DEA Schedule: CIII
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 69761-222-12

12 PELLET in 1 PACKAGE (69761-222-12)

• Marketing Start Date: 2017-11-14
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 69761-222-99 [69761022299]

Testosterone / Anastrozole PELLET

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-11-14
• Marketing End Date: 2018-04-30

NDC 69761-222-01 [69761022201]

Testosterone / Anastrozole PELLET

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2017-11-14
• Marketing End Date: 2018-04-30

Drug Details